Fingerprint
Dive into the research topics of 'Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer
E. S. Casper, R. J. Gralla, D. P. Kelsen, R. B. Natale, P. Sordillo, A. Houghton
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations